Danielle Quarles, MPH

With over 20 years of experience in clinical research, I am a strategic drug development leader who specializes in novel therapeutics such as radiotherapeutic and cell and gene therapy (CGT) clinical trials. I currently lead the clinical operations team at Convergent Therapeutics, a biotechnology company focused on developing next-generation targeted radiotherapies to treat cancer. My expertise spans across oncology, hematology, infectious diseases, vaccines, and pulmonology, with a focus on delivering complex programs while working with constrained resources and overcoming challenges unique to the novel therapeutics space. I am also passionate about diversity and inclusion, empowering women and minorities in the workplace, and striving for greater clinical trial diversity. As an alopecia areata patient advocate, I have presented at and participated in multiple events and webinars to raise awareness and educate the patient community about the drug development and clinical trials.